Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells
- PMID: 28856908
- DOI: 10.3920/BM2016.0197
Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells
Abstract
Butyrate acts as energy source for intestinal epithelial cells and as key mediator of several immune processes, modulating gene expression mainly through histone deacetylation inhibition. Thanks to these effects, butyrate has been proposed for the treatment of many intestinal diseases. Aim of this study was to investigate the effect of butyrate on the expression of a large series of target genes encoding proteins involved in pro-inflammatory pathways. We performed quantitative real-time-PCR analysis of the expression of 86 genes encoding proteins bearing to pro-inflammatory pathways, before and after butyrate exposure, in primary epithelial cells derived from human small intestine and colon. Butyrate significantly down-regulated the expression of genes involved in inflammatory response, among which nuclear factor kappa beta, interferon-gamma, Toll like 2 receptor and tumour necrosis factor-alpha. Further confirmations of these data, including studies at protein level, would support the use of butyrate as effective therapeutic strategy in intestinal inflammatory disorders.
Keywords: inflammation; membrane carrier; short chain fatty acids.
Similar articles
-
Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.Cancer Res. 2000 Aug 15;60(16):4561-72. Cancer Res. 2000. PMID: 10969808
-
Inflammation-Induced Downregulation of Butyrate Uptake and Oxidation Is Not Caused by a Reduced Gene Expression.J Cell Physiol. 2015 Feb;230(2):418-26. doi: 10.1002/jcp.24725. J Cell Physiol. 2015. PMID: 25059646
-
Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?Obes Rev. 2013 Dec;14(12):950-9. doi: 10.1111/obr.12068. Epub 2013 Aug 16. Obes Rev. 2013. PMID: 23947604 Review.
-
Enhanced production of IL-18 in butyrate-treated intestinal epithelium by stimulation of the proximal promoter region.Eur J Immunol. 2002 Sep;32(9):2635-43. doi: 10.1002/1521-4141(200209)32:9<2635::AID-IMMU2635>3.0.CO;2-N. Eur J Immunol. 2002. PMID: 12207348
-
Review article: the role of butyrate on colonic function.Aliment Pharmacol Ther. 2008 Jan 15;27(2):104-19. doi: 10.1111/j.1365-2036.2007.03562.x. Epub 2007 Oct 25. Aliment Pharmacol Ther. 2008. PMID: 17973645 Review.
Cited by
-
Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke?Evid Based Complement Alternat Med. 2021 Apr 17;2021:1391384. doi: 10.1155/2021/1391384. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33959182 Free PMC article. Review.
-
Metabolite profiling of human-originated Lachnospiraceae at the strain level.Imeta. 2022 Oct 13;1(4):e58. doi: 10.1002/imt2.58. eCollection 2022 Dec. Imeta. 2022. PMID: 38867908 Free PMC article.
-
The Immunomodulatory Functions of Butyrate.J Inflamm Res. 2021 Nov 18;14:6025-6041. doi: 10.2147/JIR.S300989. eCollection 2021. J Inflamm Res. 2021. PMID: 34819742 Free PMC article. Review.
-
High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review.Cells. 2021 Nov 14;10(11):3164. doi: 10.3390/cells10113164. Cells. 2021. PMID: 34831387 Free PMC article. Review.
-
A Narrative Review: Immunometabolic Interactions of Host-Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers.Int J Mol Sci. 2024 Aug 22;25(16):9096. doi: 10.3390/ijms25169096. Int J Mol Sci. 2024. PMID: 39201782 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
